Seattle Genetics is a Bothell, Washington-based biotech company that’s best known for developing antibody-based therapies used to treat patients with cancer. The antibody-drug conjugates or ADCs the company created have been hailed as a victory in the fight against cancer. The technology targets cancer cells and destroys them without doing harm to the healthy cells surrounding them. It also reduces the toxic effects caused by traditional cancer treatments. The technology is shared internationally through agreements with GlaxoSmithKline, Genentech, Pfizer and AbbVie and has generated over $300 million for Seattle Genetics.
The moving force behind Seattle Genetics is Dr. Clay Siegal. Trained as a researcher and with many years of experience working on anti-cancer drugs, Dr. Siegal has built Seattle Genetics on a foundation of tireless research, scientific innovation, and product development. The company has a rich development pipeline and through collaboration with other companies has over 20 ADCs in the process of clinical development. Dr. Siegal and the staff at Seattle Genetics are driven to make a difference in the lives of the children and adults forced to live with cancer.
A graduate of the University of Maryland, Dr. Siegal also has a Ph.D in Genetics from George Washington University. He is widely published and a frequent speaker at scientific conferences. He has worked with companies like Ultragenyx Pharmaceutical,
Mirna Therapeutics, Alder Biopharmaceuticals and many others involved in cancer research. But Dr. Siegal also knows that researching cancer treatment is expensive, so he has undertaken capital raising activities from public and private sources and garnered over $675 million for Seattle Genetics.
Part of the legacy of Dr. Clay Siegal at Seattle Genetics is the focus on innovation through scientific excellence, integrity, team work and mutual respect combined with an entrepreneurial spirit. The result has been groundbreaking new cancer therapies that have the potential to improve the quality of life for millions of people living with cancer. Dr. Clay Siegal has made it his mission to gather the people and resources necessary to go past what is commonly accepted about the treatment of cancer and make inroads towards finding a cure.